Bone Biologics annual operating margin
2019
2020
Bone Biologics Operating Margin Growth & History (BBLG)
Bone Biologics's operating margin was −0.08% for fiscal 2020.
View full Bone Biologics company overviewBone Biologics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −0.08% | +0.15 pp |
| 2019 | 2019-12-31 | −0.23% | — |
Bone Biologics quarterly operating margin
Q1.20
Q1.21
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2021 | 2021-03-31 | −0.02% | +0.01 pp |
| Q1 2020 | 2020-03-31 | −0.03% | — |
Bone Biologics operating margin trends
Between the periods ended 2019-12-31 and 2020-12-31, Bone Biologics's operating margin increased from −0.23% to −0.08%, a change of +0.15 percentage points. The latest reported quarter, Q1 2021, shows −0.02%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bone Biologics source filings ↗